1. Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, Eide PK, Leal PRL, Maarbjerg S, May A, Nurmikko T, Obermann M, Jensen TS, Cruccu G. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26(6):831–49.
2. Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, Obermann M, Cruccu G, Maarbjerg S. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020;19(9):784–96.
3. Bergouignan M. [Fifteen years of trial therapy of essential trigeminal neuralgia: the place of diphenylhydantoin and its derivatives]. Rev Neurol (Paris). 1958;98(5):414–6.
4. Bergouignan M. [Anti-epileptic drugs in the treatment of essential trigeminal neuralgia]. Presse Med (1893). 1970;78(42):1832–4.
5. Bergouignan M, D’Aulnay N. [Effect of diphenyl-hydantoinate salt on essential trigeminal neuralgia]. Rev Otoneuroophtalmol. 1951;23(7):427–31.